Article Details
Retrieved on: 2025-03-20 13:09:26
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses AstraZeneca's (AZN) role as a biopharmaceutical company involved in diabetes treatment options, and its market performance per Parnassus Growth Equity Fund. Its prominence among hedge funds was highlighted, despite ongoing company investigations.
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here